Affiliation:
1. Department of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai 200433, China
Abstract
Antimicrobial resistance (AMR) is growing into a major public health crisis worldwide. The reducing alternatives to conventional agents starve for novel antimicrobial agents. Due to their unique magnetic properties and excellent biocompatibility, iron oxide nanoparticles (IONPs) are the most preferable nanomaterials in biomedicine, including antibacterial therapy, primarily through reactive oxygen species (ROS) production. IONP characteristics, including their size, shape, surface charge, and superparamagnetism, influence their biodistribution and antibacterial activity. External magnetic fields, foreign metal doping, and surface, size, and shape modification improve the antibacterial effect of IONPs. Despite a few disadvantages, IONPs are expected to be promising antibacterial agents of a new generation.
Funder
National Natural Science Foundation of China Young Program
Reference98 articles.
1. Salam, M.A., Al-Amin, M.Y., Salam, M.T., Pawar, J.S., Akhter, N., Rabaan, A.A., and Alqumber, M.A.A. (2023). Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare, 11.
2. World Health Organization (2024, June 01). 10 Global Health Issues to Track in 2021. Available online: https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021.
3. O’Neill, J. (2024, June 01). Tackling Drug-Resistant Infections Globally: Final Report and Recommendations. Available online: http://amrreview.org/sites/default/files/160525_Final%20paper_with%20cover.pdf.
4. Yusuf, A., Almotairy, A.R.Z., Henidi, H., Alshehri, O.Y., and Aldughaim, M.S. (2023). Nanoparticles as drug delivery systems: A review of the implication of nanoparticles’ physicochemical properties on responses in biological systems. Polymers, 15.
5. Mabrouk, M., Das, D.B., Salem, Z.A., and Beherei, H.H. (2021). Nanomaterials for biomedical applications: Production, characterisations, recent trends and difficulties. Molecules, 26.